HARRY K. GENANT, MD (1942-2021) Osteoporosis Canada is saddened to announce the passing of Dr. Harry K. Genant, internationally renowned for his ground-breaking research in non-invasive and quantitative imaging methods […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis.

Since the COVID-19 lockdown began and even now as things begin to open up across the country, many health professionals have been consulting with their patients on-line or on the […]

Osteoporosis Canada (OC) is excited to announce the upcoming launch of the OC FLS Registry. The OC FLS Registry will be an online map profiling FLS programs across Canada, which meet OC’s Essential […]

SERMS Selective Estrogen Receptor Modulators Raloxifene (Evista®) is from a family of drugs called SERMs (Selective Estrogen Receptor Modulators). How Does Raloxifene Work? During their reproductive years, women produce significant […]

The release of the Osteoporosis Canada 2023 Clinical Practice Guideline will support Canadian healthcare providers in providing the most current evidence-based information for patient centred care to optimise skeletal health […]

Latest News IAB Membership Cycle Applications Being Accepted January 12, 2024 Canadian Institutes of Health Research (CIHR) The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

Sleeping well is vital for our overall health and well-being. The Public Health Agency of Canada recommends adults get 7 to 9 hours of sleep, however, getting quality sleep as […]